Potential Combination Therapy Approaches with Ruxolitinib in Myelofibrosis
April 26th 2023A review of recent trial data evaluating combination therapy approaches with ruxolitinib in myelofibrosis, including the rationale and potential clinical benefits associated with the use of these emerging strategies.
Read More
Darolutamide Use Is Routine in Both Doublets and Triplet Therapies in mHSPC
TAR-210 Demonstrates Preliminary Efficacy in FGFR-Altered Non–Muscle-Invasive Bladder Cancer
Dr Kutikov on Therapeutic Approaches in Urothelial Cancer Requiring Cystectomy
Dr Li on the Rationale of the MoonRISe-1 Trial in NMIBC
2 Commerce Drive
Cranbury, NJ 08512